脑再生科技（RGC）今日盘中大涨41.94%，引发市场广泛关注。该股在早盘低开后快速拉升，触及熔断机制。
此轮涨势主要受多重利好消息推动。近期，脑机接口概念股在美国、香港和中国A股市场集体爆发。马斯克旗下的Neuralink公司估值已达90亿美元，并已在第三位受试者体内植入脑机芯片，计划在2025年再植入20-30例。业内预计，未来3至5年脑机接口医疗产品有望迎来爆发期。
值得注意的是，脑再生科技作为在美上市的中概股，今年以来股价已累计上涨超过599倍，当前市值高达385亿美元（约合2772亿人民币）。该公司专注于中医药治疗神经认知障碍和退化，特别是注意力缺陷与多动障碍（ADHD）和自闭症谱系障碍（ASD）。随着脑机接口技术的快速发展，市场对脑科学相关企业的关注度持续攀升，推动了脑再生科技股价的强劲上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.